Caijun Yang

495 total citations · 1 hit paper
20 papers, 289 citations indexed

About

Caijun Yang is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Caijun Yang has authored 20 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Geriatrics and Gerontology. Recurrent topics in Caijun Yang's work include Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Economic and Financial Impacts of Cancer (4 papers). Caijun Yang is often cited by papers focused on Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Economic and Financial Impacts of Cancer (4 papers). Caijun Yang collaborates with scholars based in China, Pakistan and United Kingdom. Caijun Yang's co-authors include Ali Hassan Gillani, Yu Fang, Khezar Hayat, Shuchen Hu, Sundus Shukar, Amna Saeed, Sumaira Omer, Zaheer‐Ud‐Din Babar, Yu Fang and Jie Chang and has published in prestigious journals such as PLoS ONE, International Journal of Environmental Research and Public Health and Frontiers in Pharmacology.

In The Last Decade

Caijun Yang

19 papers receiving 275 citations

Hit Papers

Drug Shortage: Causes, Impact, and Mitigation Strategies 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caijun Yang China 8 140 49 43 35 33 20 289
Nazila Yousefi Iran 10 107 0.8× 32 0.7× 16 0.4× 34 1.0× 33 1.0× 48 270
Anandadeep Mandal United Kingdom 11 104 0.7× 74 1.5× 16 0.4× 76 2.2× 32 1.0× 30 522
Shuchen Hu China 6 123 0.9× 34 0.7× 8 0.2× 33 0.9× 31 0.9× 14 243
Hussain Abdulrahman Al‐Omar Saudi Arabia 12 62 0.4× 47 1.0× 33 0.8× 57 1.6× 23 0.7× 40 341
Abhishek Sharma United States 13 136 1.0× 46 0.9× 62 1.4× 11 0.3× 61 1.8× 32 439
I Manji Kenya 12 91 0.7× 90 1.8× 11 0.3× 42 1.2× 64 1.9× 38 351
Farzad Peiravian Iran 10 112 0.8× 23 0.5× 11 0.3× 69 2.0× 47 1.4× 53 271
Tomasz Bochenek Poland 10 200 1.4× 65 1.3× 6 0.1× 39 1.1× 53 1.6× 28 366
Saja Almazrou Saudi Arabia 10 83 0.6× 65 1.3× 10 0.2× 33 0.9× 55 1.7× 30 309
Tri Murti Andayani Indonesia 8 48 0.3× 25 0.5× 73 1.7× 18 0.5× 128 3.9× 152 370

Countries citing papers authored by Caijun Yang

Since Specialization
Citations

This map shows the geographic impact of Caijun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caijun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caijun Yang more than expected).

Fields of papers citing papers by Caijun Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caijun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caijun Yang. The network helps show where Caijun Yang may publish in the future.

Co-authorship network of co-authors of Caijun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Caijun Yang. A scholar is included among the top collaborators of Caijun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caijun Yang. Caijun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Shuchen, et al.. (2024). Changes in insulin utilization in China from 2020 to 2022. Diabetes Obesity and Metabolism. 26(12). 5681–5689. 1 indexed citations
2.
Xu, Sen, et al.. (2024). Time trends and regional variation in utilization of antidiabetic medicines in China, 2015–2022. Diabetes Obesity and Metabolism. 26(7). 2752–2760. 4 indexed citations
3.
Shukar, Sundus, et al.. (2023). Anticancer medicines in Pakistan: An analysis of essential medicines lists. Journal of Oncology Pharmacy Practice. 30(1). 46–54. 1 indexed citations
4.
Cheng, Xiang, Sha Li, Jinwei Zhang, et al.. (2023). Evaluation of the effect of managing oxycodone/acetaminophen as a psychotropic medicine: An interrupted time-series study. Frontiers in Pharmacology. 14. 1079972–1079972. 1 indexed citations
5.
Hu, Shuchen, Jinwei Zhang, Jianwei Li, et al.. (2023). The impact of drug shortages on drug prices: evidence from China. Frontiers in Public Health. 11. 1185356–1185356. 4 indexed citations
6.
Kabba, John Alimamy, Ediomo‐Ubong E. Nelson, Samuel Adu‐Gyamfi, et al.. (2023). Medicinal use of cannabis: A qualitative study of the perspectives of doctors and pharmacists from six African countries. Journal of Ethnicity in Substance Abuse. 24(3). 710–734.
7.
Shukar, Sundus, et al.. (2022). Experience of Pharmacists with Anti-Cancer Medicine Shortages in Pakistan: Results of a Qualitative Study. International Journal of Environmental Research and Public Health. 19(23). 16373–16373. 7 indexed citations
8.
Shukar, Sundus, et al.. (2022). Anti-cancer medicine shortages in an oncology tertiary hospital of Pakistan: A five-year retrospective study. Journal of Oncology Pharmacy Practice. 32(2). 263–271. 5 indexed citations
9.
Saeed, Amna, Hamid Saeed, Zikria Saleem, et al.. (2022). Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability. Frontiers in Pharmacology. 13. 820621–820621. 8 indexed citations
10.
Hu, Shuchen, et al.. (2022). Procurement of medicines to treat cancer, 2015–2020, China. Bulletin of the World Health Organization. 100(12). 758–768. 3 indexed citations
11.
Cheng, Xiang, et al.. (2021). Clinical Consumption of Compound Opioid Analgesics in China: A Retrospective Analysis of National Data 2015–2018. Biological and Pharmaceutical Bulletin. 44(9). 1316–1322. 1 indexed citations
12.
Omer, Sumaira, et al.. (2021). A Qualitative Study Exploring the Management of Medicine Shortages in the Community Pharmacy of Pakistan. International Journal of Environmental Research and Public Health. 18(20). 10665–10665. 1 indexed citations
14.
Shukar, Sundus, Khezar Hayat, Amna Saeed, et al.. (2021). Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in Pharmacology. 12. 161 indexed citations breakdown →
16.
Aziz, Muhammad Majid, Minghuan Jiang, Imran Masood, et al.. (2019). Patients’ Anticipation for the Pharmacies of Rural Communities: A Qualitative Study from Pakistan. International Journal of Environmental Research and Public Health. 16(1). 143–143. 11 indexed citations
17.
Yang, Caijun, et al.. (2018). The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians. PLoS ONE. 13(10). e0205238–e0205238. 12 indexed citations
18.
Gillani, Ali Hassan, Muhammad Majid Aziz, Imran Masood, et al.. (2018). Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan. Expert Review of Pharmacoeconomics & Outcomes Research. 18(6). 647–653. 15 indexed citations
19.
Gillani, Ali Hassan, Amirul Islam, Khezar Hayat, et al.. (2018). Knowledge, Attitudes and Practices Regarding Diabetes in the General Population: A Cross-Sectional Study from Pakistan. International Journal of Environmental Research and Public Health. 15(9). 1906–1906. 38 indexed citations
20.
Yang, Caijun, et al.. (1997). Expectancy of working life of mine workers in hunan province. Public Health. 111(2). 81–83. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026